LIFESTAT – Living with statins: An interdisciplinary project on the use of statins as a cholesterol-lowering treatment and for cardiovascular risk reduction

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

LIFESTAT – Living with statins : An interdisciplinary project on the use of statins as a cholesterol-lowering treatment and for cardiovascular risk reduction. / Christensen, Christa Lykke; Helge, Jørn Wulff; Krasnik, Allan; Kriegbaum, Margit; Rasmussen, Lene Juel; Hickson, Ian David; Liisberg, Kasper Bering; Oxlund, Bjarke; Bruun, Birgitte; Lau, Sofie Rosenlund; Olsen, Maria Nathalie Angleys; Andersen, John Sahl; Heltberg, Andreas Søndergaard; Kuhlman, Anja Christine Birk; Morville, Thomas Hoffmann; Dohlmann, Tine Lovsø; Larsen, Steen; Dela, Flemming.

I: Scandinavian Journal of Public Health, Bind 44, Nr. 5, 2016, s. 534-539.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Christensen, CL, Helge, JW, Krasnik, A, Kriegbaum, M, Rasmussen, LJ, Hickson, ID, Liisberg, KB, Oxlund, B, Bruun, B, Lau, SR, Olsen, MNA, Andersen, JS, Heltberg, AS, Kuhlman, ACB, Morville, TH, Dohlmann, TL, Larsen, S & Dela, F 2016, 'LIFESTAT – Living with statins: An interdisciplinary project on the use of statins as a cholesterol-lowering treatment and for cardiovascular risk reduction', Scandinavian Journal of Public Health, bind 44, nr. 5, s. 534-539. https://doi.org/10.1177/1403494816636304

APA

Christensen, C. L., Helge, J. W., Krasnik, A., Kriegbaum, M., Rasmussen, L. J., Hickson, I. D., ... Dela, F. (2016). LIFESTAT – Living with statins: An interdisciplinary project on the use of statins as a cholesterol-lowering treatment and for cardiovascular risk reduction. Scandinavian Journal of Public Health, 44(5), 534-539. https://doi.org/10.1177/1403494816636304

Vancouver

Christensen CL, Helge JW, Krasnik A, Kriegbaum M, Rasmussen LJ, Hickson ID o.a. LIFESTAT – Living with statins: An interdisciplinary project on the use of statins as a cholesterol-lowering treatment and for cardiovascular risk reduction. Scandinavian Journal of Public Health. 2016;44(5):534-539. https://doi.org/10.1177/1403494816636304

Author

Christensen, Christa Lykke ; Helge, Jørn Wulff ; Krasnik, Allan ; Kriegbaum, Margit ; Rasmussen, Lene Juel ; Hickson, Ian David ; Liisberg, Kasper Bering ; Oxlund, Bjarke ; Bruun, Birgitte ; Lau, Sofie Rosenlund ; Olsen, Maria Nathalie Angleys ; Andersen, John Sahl ; Heltberg, Andreas Søndergaard ; Kuhlman, Anja Christine Birk ; Morville, Thomas Hoffmann ; Dohlmann, Tine Lovsø ; Larsen, Steen ; Dela, Flemming. / LIFESTAT – Living with statins : An interdisciplinary project on the use of statins as a cholesterol-lowering treatment and for cardiovascular risk reduction. I: Scandinavian Journal of Public Health. 2016 ; Bind 44, Nr. 5. s. 534-539.

Bibtex

@article{cb49b831a9e3469dbd90950cb9d1e0c1,
title = "LIFESTAT – Living with statins: An interdisciplinary project on the use of statins as a cholesterol-lowering treatment and for cardiovascular risk reduction",
abstract = "AIM:LIFESTAT is an interdisciplinary project that leverages approaches and knowledge from medicine, the humanities and the social sciences to analyze the impact of statin use on health, lifestyle and well-being in cohorts of Danish citizens. The impetus for the study is the fact that 10{\%} of the population in the Scandinavian countries are treated with statins in order to maintain good health and to avoid cardiovascular disease by counteracting high blood levels of cholesterol. The potential benefit of treatment with statins should be considered in light of evidence that statin use has prevalent and unintended side effects (e.g. myalgia, and glucose and exercise intolerance).METHODS:The LIFESTAT project combines invasive human experiments, biomedical analyses, nationwide surveys, epidemiological studies, qualitative interviews, media content analyses, and ethnographic participant observations. The study investigates the biological consequences of statin treatment; determines the mechanism(s) by which statin use causes muscle and mitochondrial dysfunction; and analyzes achievement of treatment goals, people's perception of disease risk, media influence on people's risk and health perception, and the way people manage to live with the risk (personally, socially and technologically). CONCLUSIONS THE ORIGINALITY AND SUCCESS OF LIFESTAT DEPEND ON AND DERIVE FROM ITS INTERDISCIPLINARY APPROACH, IN WHICH THE DISCIPLINES CONVERGE INTO THOROUGH AND HOLISTIC STUDY AND DESCRIBE THE IMPACT OF STATIN USE ON THE EVERYDAY LIFE OF STATIN USERS THIS HAS THE POTENTIAL FOR MUCH GREATER BENEFIT THAN ANY ONE OF THE DISCIPLINES ALONE INTEGRATING TRADITIONAL DISCIPLINES PROVIDES NOVEL PERSPECTIVES ON POTENTIAL CURRENT AND FUTURE SOCIAL, MEDICAL AND PERSONAL BENEFITS OF STATIN USE.",
author = "Christensen, {Christa Lykke} and Helge, {J{\o}rn Wulff} and Allan Krasnik and Margit Kriegbaum and Rasmussen, {Lene Juel} and Hickson, {Ian David} and Liisberg, {Kasper Bering} and Bjarke Oxlund and Birgitte Bruun and Lau, {Sofie Rosenlund} and Olsen, {Maria Nathalie Angleys} and Andersen, {John Sahl} and Heltberg, {Andreas S{\o}ndergaard} and Kuhlman, {Anja Christine Birk} and Morville, {Thomas Hoffmann} and Dohlmann, {Tine Lovs{\o}} and Steen Larsen and Flemming Dela",
year = "2016",
doi = "10.1177/1403494816636304",
language = "English",
volume = "44",
pages = "534--539",
journal = "Scandinavian Journal of Public Health",
issn = "1403-4948",
publisher = "SAGE Publications",
number = "5",

}

RIS

TY - JOUR

T1 - LIFESTAT – Living with statins

T2 - An interdisciplinary project on the use of statins as a cholesterol-lowering treatment and for cardiovascular risk reduction

AU - Christensen, Christa Lykke

AU - Helge, Jørn Wulff

AU - Krasnik, Allan

AU - Kriegbaum, Margit

AU - Rasmussen, Lene Juel

AU - Hickson, Ian David

AU - Liisberg, Kasper Bering

AU - Oxlund, Bjarke

AU - Bruun, Birgitte

AU - Lau, Sofie Rosenlund

AU - Olsen, Maria Nathalie Angleys

AU - Andersen, John Sahl

AU - Heltberg, Andreas Søndergaard

AU - Kuhlman, Anja Christine Birk

AU - Morville, Thomas Hoffmann

AU - Dohlmann, Tine Lovsø

AU - Larsen, Steen

AU - Dela, Flemming

PY - 2016

Y1 - 2016

N2 - AIM:LIFESTAT is an interdisciplinary project that leverages approaches and knowledge from medicine, the humanities and the social sciences to analyze the impact of statin use on health, lifestyle and well-being in cohorts of Danish citizens. The impetus for the study is the fact that 10% of the population in the Scandinavian countries are treated with statins in order to maintain good health and to avoid cardiovascular disease by counteracting high blood levels of cholesterol. The potential benefit of treatment with statins should be considered in light of evidence that statin use has prevalent and unintended side effects (e.g. myalgia, and glucose and exercise intolerance).METHODS:The LIFESTAT project combines invasive human experiments, biomedical analyses, nationwide surveys, epidemiological studies, qualitative interviews, media content analyses, and ethnographic participant observations. The study investigates the biological consequences of statin treatment; determines the mechanism(s) by which statin use causes muscle and mitochondrial dysfunction; and analyzes achievement of treatment goals, people's perception of disease risk, media influence on people's risk and health perception, and the way people manage to live with the risk (personally, socially and technologically). CONCLUSIONS THE ORIGINALITY AND SUCCESS OF LIFESTAT DEPEND ON AND DERIVE FROM ITS INTERDISCIPLINARY APPROACH, IN WHICH THE DISCIPLINES CONVERGE INTO THOROUGH AND HOLISTIC STUDY AND DESCRIBE THE IMPACT OF STATIN USE ON THE EVERYDAY LIFE OF STATIN USERS THIS HAS THE POTENTIAL FOR MUCH GREATER BENEFIT THAN ANY ONE OF THE DISCIPLINES ALONE INTEGRATING TRADITIONAL DISCIPLINES PROVIDES NOVEL PERSPECTIVES ON POTENTIAL CURRENT AND FUTURE SOCIAL, MEDICAL AND PERSONAL BENEFITS OF STATIN USE.

AB - AIM:LIFESTAT is an interdisciplinary project that leverages approaches and knowledge from medicine, the humanities and the social sciences to analyze the impact of statin use on health, lifestyle and well-being in cohorts of Danish citizens. The impetus for the study is the fact that 10% of the population in the Scandinavian countries are treated with statins in order to maintain good health and to avoid cardiovascular disease by counteracting high blood levels of cholesterol. The potential benefit of treatment with statins should be considered in light of evidence that statin use has prevalent and unintended side effects (e.g. myalgia, and glucose and exercise intolerance).METHODS:The LIFESTAT project combines invasive human experiments, biomedical analyses, nationwide surveys, epidemiological studies, qualitative interviews, media content analyses, and ethnographic participant observations. The study investigates the biological consequences of statin treatment; determines the mechanism(s) by which statin use causes muscle and mitochondrial dysfunction; and analyzes achievement of treatment goals, people's perception of disease risk, media influence on people's risk and health perception, and the way people manage to live with the risk (personally, socially and technologically). CONCLUSIONS THE ORIGINALITY AND SUCCESS OF LIFESTAT DEPEND ON AND DERIVE FROM ITS INTERDISCIPLINARY APPROACH, IN WHICH THE DISCIPLINES CONVERGE INTO THOROUGH AND HOLISTIC STUDY AND DESCRIBE THE IMPACT OF STATIN USE ON THE EVERYDAY LIFE OF STATIN USERS THIS HAS THE POTENTIAL FOR MUCH GREATER BENEFIT THAN ANY ONE OF THE DISCIPLINES ALONE INTEGRATING TRADITIONAL DISCIPLINES PROVIDES NOVEL PERSPECTIVES ON POTENTIAL CURRENT AND FUTURE SOCIAL, MEDICAL AND PERSONAL BENEFITS OF STATIN USE.

U2 - 10.1177/1403494816636304

DO - 10.1177/1403494816636304

M3 - Journal article

VL - 44

SP - 534

EP - 539

JO - Scandinavian Journal of Public Health

JF - Scandinavian Journal of Public Health

SN - 1403-4948

IS - 5

ER -

ID: 159062627